Lipoprotein(a) concentrations and non-insulin-dependent diabetes mellitus: Relationship to glycaemic control and diabetic complications

Diabetes Research and Clinical Practice

Volumn 33, Issue 2, 1996, Pages 105-110

  Chico, Ana ^a   Pérez, Antonio ^a   Caixàs, Assumpta ^a   Ordóñez, Jordi ^a   Pou, Josep M ^a   De Leiva, Alberto ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Cardiovascular disease; Diabetic complications; Glycaemic control; Lipoprotein(a); Non insulin dependent diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0030197662     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(96)01285-5     Document Type: Article

References (44)

1. [1] Berg, K. (1963) A new serum type system in man. The Lp system. Acta Pathol. Microbiol. Scand. 59, 369-382.
2. [2] Hoefler, G., Harnoncourt. F., Paschke, E., Mirtl, W., Pfeiffer, K.H. and Kostner, G.M. (1988) Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis 8, 398-401.
3. [3] Heller, F.R., Jamart, J., Honore, P. et al. (1993) Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care 16, 819-823.
4. [4] Haffner, S.M., Morales, P.A., Stern, M.P. and Gruber, M.K. (1992) Lp(a) concentrations in NIDDM. Diabetes 41, 1267-1272.
5. [5] Maser, R.E., Usher, D., Becker, D.J., Drash, A.L., Kuller, L.H. and Orchard, T.J. (1993) Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh epidemiology of diabetes complications study cohort. Diabetes Care 16, 755-758.
6. [6] Velho, G., Erlich, D., Turpin, E. et al. (1993) Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care 16, 745-747.
7. [7] Jenkins, A.J., Steele, J.S., Janus, E.D., Santamaria, J.D. and Best, J.D. (1992) Plasma apolipoprotein(a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35, 1055-1059.
8. [8] Rainwater, D.E., MacCluer, J.W., Stern, M.P., VandeBerg, J.E. and Haffner, S.M. (1994) Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes 43, 942-946.
9. [9] O'Brien, T., Nguyen, T.T., Harrison, J.M., Bailey, K.R., Dick, P.J. and Kottke, B.A. (1994) Eipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus. Mayo Clin. Proc. 69, 430-435.
10. [10] Haffner, S.M., Klein, B.E.K., Moss, S.E. and Klein, R. (1992) Lack of association between Lp(a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin epidemiologic survey of diabetes retinopathy. Metabolism 41, 194-197.
11. [11] Haffner, S.M., Tuttle, K.R. and Rainwater, D.L. (1992) Lack of change of lipoprotein(a) concentration with improved glycemic control in subjects with type II diabetes. Metabolism 41, 116-120.
12. [12] Jenkins, A.J. and Best, J.D. (1995) The role of lipoprotein(a) in the vascular complications of diabetes mellitus. J. Intern. Med. 237, 359-365.
13. [13] National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039-1057.
14. [14] McLean, J.W., Tomlinson, J.E., Kuang, W.J. et al. (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330, 132-137.
15. [15] Utermann, G. and Weber, W. (1983) Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 154, 357-361.
16. [16] Utermann, G., Menzel, H.J.K., Kraft, H.G., Duba, H.C., Kemmler, H.G. and Seitz, C. (1987) Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80, 458-465.
17. [17] Gaubatz, J.W., Ghanem, K.I., Guevara, J., Nava, M.L., Patsch, W. and Morrisen, J.D. (1990) Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weight to plasma levels of lipoprotein(a). J. Lipid Res. 31, 603-613.
18. [18] Sandkamp, M., Funke, H., Schulte, H., Köhler, E. and Assman, G. (1990) Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin. Chem. 36, 20-23.
19. [19] Durrington, P.N., Ishola, M., Hunt, L., Arrol, S. and Bhatnagar, D. (1988) Apolipoproteins(a), AI and B and parenteral history in men with early onset ischaemic heart disease. Lancet 1, 1070-1073.
20. [20] Kark, J.D., Sandholzer, C., Friedlander, Y. and Utermann, G. (1993) Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. Atherosclerosis 98, 139-151.
21. [21] MBewu, A.D. and Durrington, P.N. (1990) Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85, 1-14.
22. [22] Scanu, A.M. (1991) Lipoprotein(a) and atherosclerosis. Ann. Intern. Med. 115, 209-218.
23. [23] Dahlen, G.H. (1994) Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108, 111-126.
24. [24] Scanu, A.M. (1992) Lipoprotein(a). A genetic risk factor for premature coronary heart disease. JAMA 267, 3326-3329.
25. [25] Utermann, G. (1989) The mysteries of lipoprotein(a). Science 216, 902-910.
26. [26] Ramírez, L.C., Arauz-Pacheco, C., Lackner, C., Albright, G., Adams, B.V. and Raskin, P. (1992) Lipoprotein(a) levels in diabetes mellitus: relationship to metabolic control. Ann. Intern. Med. 117, 42-47.
27. [27] Nakata, H., Horita, K. and Eto, M. (1993) Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications. Metabolism 42, 1323-1326.
28. [28] Yamasaki, Y., Watarai, T., Kawamori, R., Kanda, T. and Kamada, T. (1992) Lp(a) in Japanese diabetic children. Diabetes Care 15, 1112-1113.
29. [29] Chang, C.J., Kao, J.T., Wu, T.J. et al. (1995) Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Diabetes Care 18, 1191-1194.
30. [30] Wolffenbuttel, B.H., Leurs, P.B., Sels, J.P. et al. (1993) Improved blood glucose control in insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels. Diabetic Med. 5, 427-430.
31. [31] Heller, F.R., Jamart, J. and Honore, P. (1993) Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care 16, 819-823.
32. [32] Robbins, D.C. and Howard, B.V. (1991) Lipoprotein(a) and diabetes. Diabetes Care 14, 347-349.
33. [33] Sonnichsen, A.C., Ricther, W.O. and Schwandt, P. (1990) Reduction of Lp(a) by weight loss. Ent. J. Obes. 14, 487-494.
34. [34] dePergola, G.D., Giorgino, F., Cospite, M.R. and Giagulli, V.A. (1993) Relation between sex hormones and serum hpoprotein and lipoprotein(a) concentrations in premenopausal obese women. Arterioscler. Thromb. 13, 675-679.
35. [35] Sundell, I.B., Nilsson, T.K., Hallmans, G., Hellsten, G. and Dahlen, G.H. (1989) Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein(a), and established cardiovascular risk factors in a North Swedish population. Atherosclerosis 80, 9-16.
36. [36] Makino, K., Josephson, M., Fellner, S.K. and Scanu, A.M. (1993) Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus. Atherosclerosis 98, 255-256.
37. [31] Guillausseau, P.J., Peynet, J., Chanson, P. et al. (1992) Lipoprotein(a) in diabetic patients with and without chronic renal failure. Diabetes Care 15, 976-979.
38. [38] Jenkins, A.J., Steele, J.S., Janus, E.D. and Best, J.D. (1991) Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 40, 787-790.
39. [39] Kapelrud, H., Bangstad, H.J., Jorgensen, K.D., Berg, K. and Hanssen, K.F. (1991) Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. Br. Med. J. 303, 675-677.
40. [40] Haffner, S.M., Morales, P.A., Gruber, M.K., Hazuda, H.P. and Stern, M.P. (1993) Lack of association of lipids, lipoproteins and Lp(a) with microalbuminuria in NIDDM. Arterioscler. Thromb. 13, 205-210.
41. [41] Girelli, A., Cimino, A. and Rocca, L. (1994) Serum lipoprotein(a) is not increased in NIDDM patients with microalbuminuria. Diabetes Care 17, 456-457.
42. [42] Velho, G., Erlich, D. and Turpin, E. (1993) Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care 16, 744-747.
43. [43] Niskanen, L., Mykkänen, L., Karonen, S.L. and Uusitupa, M. (1993) Apoprotein(a) levels in relation to coronary heart disease and risk factors in type II (non-insulin-dependent diabetes). Cardiovasc. Risk Factors 13, 205-210.
44. [44] Hiraga, T., Kobayashi, T., Okubo, M. et al. (1995) Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 18, 241-244.